Cargando…
Experimental Pharmacotherapy for COVID-19: The Latest Advances
The coronavirus infectious disease-2019 (COVID-19) has overwhelmed like a shock wave in a completely unprepared world. Despite coronavirus infections were involved in previous epidemic outbreaks, no antiviral agent was developed for specific treatment. As a consequence, since the beginning of this p...
Autores principales: | Pagliano, Pasquale, Scarpati, Giuliana, Sellitto, Carmine, Conti, Valeria, Spera, Anna Maria, Ascione, Tiziana, Piazza, Ornella, Filippelli, Amelia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7800714/ https://www.ncbi.nlm.nih.gov/pubmed/33442304 http://dx.doi.org/10.2147/JEP.S255209 |
Ejemplares similares
-
COVID-19: a confirmed case of reinfection in a nurse
por: Scarpati, Giuliana, et al.
Publicado: (2021) -
KL-6 in ARDS and COVID-19 Patients
por: Piazza, Ornella, et al.
Publicado: (2022) -
Effect of Tocilizumab in Reducing the Mortality Rate in COVID-19 Patients: A Systematic Review with Meta-Analysis
por: Conti, Valeria, et al.
Publicado: (2021) -
Characteristics of viral pneumonia in the COVID-19 era: an update
por: Pagliano, P., et al.
Publicado: (2021) -
Comment on Guerrero-Romero et al. Magnesium-to-Calcium Ratio and Mortality from COVID-19. Nutrients 2022, 14, 1686
por: Scarpati, Giuliana, et al.
Publicado: (2022)